C-reactive protein levels and outcomes after statin therapy.
Jaber
Bertrand L
BL
Madias
Nicolaos E
NE
D002097:C-Reactive Protein / Q000378:metabolism*; D008078:Cholesterol, LDL / Q000097:blood; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D015850:Interleukin-6 / Q000097:blood; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy* / Q000517:prevention & control; D009569:Nitric Oxide / Q000096:biosynthesis; D012307:Risk Factors; D055502:Secondary Prevention; D015854:Up-Regulation
D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D015850:Interleukin-6; D009569:Nitric Oxide; D002097:C-Reactive Protein